Keyphrases
Gastric Cancer
100%
Microsatellite Instability-high (MSI-H)
85%
Tumor
69%
Hereditary Colorectal Cancer Syndromes
40%
Loss of Heterozygosity
36%
Gastric Carcinoma
35%
E-cadherin
32%
Neoadjuvant
27%
Carcinoma
27%
Germline mutation
25%
5-fluorouracil (5-FU)
23%
Polymorphism
22%
MLH1
20%
Colorectal Cancer
20%
Neoadjuvant Chemotherapy
20%
Upper Gastrointestinal Tract
18%
Hereditary Diffuse Gastric Cancer
16%
Mutation Carriers
16%
Gastric Cancer Patients
16%
Germ Cells
16%
Cisplatin
15%
Chemotherapy
15%
MSH2
15%
Overall Survival
14%
Prognostic Impact
13%
Diffuse-type Gastric Cancer
13%
E-cadherin mutations
13%
Epidermal Growth Factor Receptor
13%
Remnant Gastric Cancer
13%
CDH1
12%
TP53 mutation
12%
CDH1 mutation
12%
Non-associated
12%
Cyclin D1 (CCND1)
11%
Cetuximab
11%
Genotype
11%
Microsatellites
11%
Esophageal Adenocarcinoma
10%
Immunohistochemistry
10%
E-cadherin Gene
10%
Adenocarcinoma
10%
Cancer Families
10%
Response Prediction
10%
MSH6
9%
Adenoma
9%
Chromosomal Instability
9%
Response to Neoadjuvant Chemotherapy
9%
Allelic Loss
9%
Gene Expression
9%
Neoadjuvant Therapy
9%
Biochemistry, Genetics and Molecular Biology
Microsatellite Instability
63%
Loss of Heterozygosity
36%
Microsatellite
35%
Cadherin
32%
Germline Mutation
29%
MLH1
24%
Genetics
23%
Overall Survival
22%
Cisplatin
20%
MSH2
19%
P53
17%
Upper Digestive Tract
17%
Fluorouracil
16%
Promoter Region
16%
DNA Mismatch Repair
16%
Colon
15%
Germline
15%
Germ Cell
15%
Methylation
12%
Genomics
12%
Genotyping
12%
Exon
12%
Esophagus
11%
Gene Expression
11%
Epidermal Growth Factor Receptor
11%
KRAS
11%
Gene Mutation
10%
Carcinogenesis
9%
MSH6
8%
Chromosome Instability
8%
Cyclin D1
8%
DNA Repair
8%
Oncogene
7%
Tumor Suppressor Gene
7%
Messenger RNA
7%
Thymidylate Synthase
7%
Genetic Predisposition
7%
Allelic Imbalance
6%
Genetic Heterogeneity
6%
Cell Adhesion Proteins
6%
Real-Time Polymerase Chain Reaction
6%
Drug Resistance
6%
Cancer Cell
6%
MUTYH
5%
Epimutation
5%
Oxidoreductase
5%
Missense Mutation
5%
Protein P53
5%
Epstein Barr Virus
5%
Mutation Rate
5%
Medicine and Dentistry
Abdominal Cancer
61%
Neoplasm
57%
Microsatellite Instability
27%
Hereditary Nonpolyposis Colorectal Cancer
22%
Carcinoma
20%
Germline Mutation
20%
Stomach Carcinoma
19%
Colorectal Carcinoma
19%
Neoadjuvant Chemotherapy
16%
Protein P53
15%
Uvomorulin
15%
Adenocarcinoma
15%
Heterozygosity
13%
Malignant Neoplasm
13%
Overall Survival
12%
Adenoma
11%
Diseases
10%
Biological Marker
10%
DNA Mismatch Repair
10%
Prognostic Factor
10%
Stomach Adenocarcinoma
9%
Cisplatin
8%
Hereditary Diffuse Gastric Cancer
8%
Colon Carcinoma
8%
Gene Expression
8%
Exon
7%
Cancer
7%
Immunohistochemistry
7%
Gastrectomy
7%
Upper Digestive Tract
7%
Neuroendocrine Carcinoma
6%
Esophageal Adenocarcinoma
6%
Biopsy Technique
6%
Surgery
6%
Chromosomal Instability
6%
Methylation
6%
Formaldehyde
5%
Oxidoreductase
5%
Breast Carcinoma
5%
Hereditary Colorectal Cancer
5%
Histone Deacetylase 2
5%
HDAC1
5%
Cyclin D1
5%
Molecular Pathology
5%
Recurrent Disease
5%
Medicine
5%
Germ Cell
5%
Hazard Ratio
5%
Rectum Cancer
5%
Tumor Regression
5%